After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Stoke Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Stoke Therapeutics Inc is $604.17M. A total of 1.06 million shares were traded on the day, compared to an average of 1.11M shares.
In the most recent transaction, Skorpios Trust sold 3,600,000 shares of STOK for 11.60 per share on Apr 17 ’24. After the transaction, the 10% Owner now owns 10,843,681 company shares. In a previous transaction on Apr 01 ’24, Nash Huw M. sold 61,329 shares at 13.23 per share. STOK shares that COO & CBO owns now total 0.
Among the insiders who sold shares, Ticho Barry disposed of 9,426 shares on Apr 01 ’24 at a per-share price of $13.23. This resulted in the CHIEF MEDICAL OFFICER holding 2,485 shares of STOK after the transaction. In another insider transaction, Allan Jonathan sold 5,126 shares at $13.20 per share on Mar 28 ’24. Company shares held by the GENERAL COUNSEL & CORP SEC now total 2,598.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, STOK has a high of $16.40 and a low of $3.35.
As of this writing, STOK has an earnings estimate of $Spok Holdings, Inc. per share for the current quarter. EPS was calculated based on a consensus of Shattuck Labs, Inc. estimates, with a high estimate of $Strive 2000 ETF per share and a lower estimate of $Stoke Therapeutics, Inc..
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. STOK’s latest balance sheet shows that the firm has $219.81M in Cash & Short Term Investments as of fiscal 2021. There were $1.51M in debt and $17.14M in liabilities at the time. Its Book Value Per Share was $3.47, while its Total Shareholder’s Equity was $217.78M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for STOK is Buy with a score of 4.67.
